2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with sri 63-675 in 1 studies
| Studies (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Trials (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Recent Studies (post-2010) (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Studies (sri 63-675) | Trials (sri 63-675) | Recent Studies (post-2010) (sri 63-675) |
|---|---|---|---|---|---|
| 63 | 0 | 0 | 21 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishara, SM; Bloch, KJ; Bloch, M; Ng, BP | 1 |
1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and sri 63-675
| Article | Year |
|---|---|
Inhibition of immune complex-induced enteropathy by three different platelet-activating factor receptor antagonists.
Topics: Animals; Antibodies; Antigen-Antibody Complex; Azepines; Furans; Intestinal Diseases; Male; Platelet Membrane Glycoproteins; Quinolines; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serum Albumin, Bovine; Triazoles | 1991 |